Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: The research emphasis in anti-cancer drug discovery has always been to search for a drug with the greatest antitumor potential but fewest side effects. This can only be achieved if the drug used is against a specific target located in the tumor cells. In this study, we evaluated Minichromosome Maintenance Protein 7 (MCM7) as a novel therapeutic target in cancer. RESULTS: Immunohistochemical analysis showed that MCM7 was positively stained in 196 of 331 non-small cell lung cancer (NSCLC), 21 of 29 bladder tumor and 25 of 70 liver tumor cases whereas no significant staining was observed in various normal tissues. We also found an elevated expression of MCM7 to be associated with poor prognosis for patients with NSCLC (P = 0.0055). qRT-PCR revealed a higher expression of MCM7 in clinical bladder cancer tissues than in corresponding non-neoplastic tissues (P < 0.0001), and we confirmed that a wide range of cancers also overexpressed MCM7 by cDNA microarray analysis. Suppression of MCM7 using specific siRNAs inhibited incorporation of BrdU in lung and bladder cancer cells overexpressing MCM7, and suppressed the growth of those cells more efficiently than that of normal cell strains expressing lower levels of MCM7. CONCLUSIONS: Since MCM7 expression was generally low in a number of normal tissues we examined, MCM7 has the characteristics of an ideal candidate for molecular targeted cancer therapy in various tumors and also as a good prognostic biomarker for NSCLC patients.

Original publication

DOI

10.1186/1476-4598-10-65

Type

Journal article

Journal

Mol Cancer

Publication Date

28/05/2011

Volume

10

Keywords

Biomarkers, Tumor, Carcinoma, Non-Small-Cell Lung, Cell Cycle Proteins, Cell Line, Tumor, Cell Proliferation, DNA-Binding Proteins, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Gene Silencing, HCT116 Cells, HEK293 Cells, HeLa Cells, Hep G2 Cells, Humans, Lung Neoplasms, Minichromosome Maintenance Complex Component 7, Neoplasms, Nuclear Proteins, Prognosis, Protein Binding, Protein-Arginine N-Methyltransferases, RNA, Small Interfering